I think that most of you are not seeing the forest because of the trees ...
Management took six months longer than we were expecting (and what should have been the case) to get in-house production up and running and now after 18 months of post-approval very expensive selling of cardiocell world-wide the repeat sales volumes are so pathetic that Admedus management are not yet advertising for additional staff so as to install a second production line and are remaining suspiciously silent.
And it is now obvious that they are slowing down development activity, for example we are only now seeing recruiting adverts for the herpes trial subjects ... these ads should have been in the media back in Sept so the first injections could have been administered prior to Xmas... that's right, we are now 4 months late on the vaccine trial.
I think that most of you are not seeing the forest because of...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.15 |
Change
0.000(0.00%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.15 | $14.60 | $347.8K | 23.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 760 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.15 | 388 | 1 |
View Market Depth
| Last trade - 15.58pm 30/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |